ADiTx Therapeutics, Inc Earning Date (ADTX)

USA |NASDAQ |USD

ADTX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jun 30, 2022 (est) Mar 31, 2022 $0.11 $-0.31 $-0.42
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jun 30, 2022 (est) Mar 31, 2022 $10.02M $105.03K $0.00

Aditx Therapeutics, Inc's next estimated earnings date (based on same quarter last year's date) is Jun 30, 2022 for the fiscal quarter ending Mar 31, 2022.

ADTX Earnings Date & History Chart

ADTX Earnings & Revenue Forecast

ADTX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $0.44 $0.44 $0.44

ADTX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $0.44 $0.44 $0.44

ADTX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 1 $41.74M $41.74M $41.74M

ADTX Earnings Date & Revenue History

ADTX Earnings History

|
Show More
Show More

ADTX Revenue History

|
Show More
Show More

Aditx Therapeutics, Inc Next Earnings Date & Report

ADTX Mar 2022 (FQ) Earnings Date & Report Preview

ADTX's next estimated earnings date (based on same quarter last year's report date) is Jun 30, 2022 for the fiscal quarter ending Mar 31, 2022.

Aditx Therapeutics, Inc Previous Earnings Dates & Reports

ADTX Previous Earnings Date & Report Recap: Dec 2021 (FQ)

Aditx Therapeutics, Inc's previous earnings date was Mar 31, 2022 for its fiscal quarter ended Dec 31, 2021.

ADTX's earnings per share (EPS) was $-0.31, missing the consensus analysts forecast of $0.23 by -234.78%.

The EPS was higher than the previous fiscal quarter (Sep 2021) by -44.64%, and higher than the same period a year before (Dec 2020) by -32.80%.

Revenues were $105.03K.

The company reported a net income of $-24.05M.

Free cash flow for the quarter was $-8.81M , compared to $-4.71M last quarter and $-3.16M a year before.

ADTX Previous Earnings Date & Report Recap: Dec 2021 (FY)

Aditx Therapeutics, Inc's previous annual earnings date was Mar 31, 2022 for its fiscal year ended Dec 31, 2021.

ADTX's earnings per share (EPS) was $-1.86, missing the consensus analysts forecast of $-0.85 by 118.33% , and lower than the previous year's EPS (Dec 2020) by 37.91%.

Revenues were $105.03K.

The company reported a net income of $-46.37M.

Aditx Therapeutics, Inc reported a free cash flow of $-23.29M for its fiscal year, compared to $-7.39M a year ago.